These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3570156)

  • 21. Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.
    Higashi T
    Gastroenterol Jpn; 1982 Apr; 17(2):125-34. PubMed ID: 7106499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
    He X; Luan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of viable isolated hepatocytes or hepatocyte fractions on survival rate following galactosamine-induced acute liver failure.
    ten Berg RG; Ernst P; van Maldegem-Dronkers C; Marquet R; Westbroek DL
    Eur Surg Res; 1985; 17(2):109-18. PubMed ID: 3884339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
    Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
    Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbances in the permeability of the cerebral blood vessels in experimental hepatic encephalopathy.
    Mossakowski MJ; Smialek M; Pronaszko A
    Pol Med J; 1971; 10(1):208-17. PubMed ID: 5573905
    [No Abstract]   [Full Text] [Related]  

  • 27. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Size-dependent blood-brain barrier opening demonstrated with [14C]sucrose and a 200,000-Da [3H]dextran.
    Armstrong BK; Robinson PJ; Rapoport SI
    Exp Neurol; 1987 Sep; 97(3):686-96. PubMed ID: 2442027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.
    Bassett ML; Mullen KD; Scholz B; Fenstermacher JD; Jones EA
    Gastroenterology; 1990 Mar; 98(3):747-57. PubMed ID: 2298374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization.
    Traber P; DalCanto M; Ganger D; Blei AT
    Gastroenterology; 1989 Mar; 96(3):885-91. PubMed ID: 2914649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggravating action of zymosan on acute liver damage in perfused liver of rats treated with D-galactosamine.
    Cui TX; Iwai M; Yamauchi T; Shimazu T
    Am J Physiol; 1998 Dec; 275(6):G1361-6. PubMed ID: 9843773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.
    Yamamoto S; Nguyen JH
    J Surg Res; 2006 Aug; 134(2):307-14. PubMed ID: 16488444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of hepatotoxicity by macrophages in the liver.
    Shiratori Y; Kawase T; Shiina S; Okano K; Sugimoto T; Teraoka H; Matano S; Matsumoto K; Kamii K
    Hepatology; 1988; 8(4):815-21. PubMed ID: 2839405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the permeability of the blood-retinal barrier in hypertensive rats.
    Lightman S; Rechthand E; Latker C; Palestine A; Rapoport S
    Hypertension; 1987 Oct; 10(4):390-5. PubMed ID: 3653967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.
    Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H
    Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute hepatic insufficiency in guinea pigs. Experimental model caused by the injection of monoethanolamine oleate].
    de Macedo AR; Bacchi CE; Spadella CT; Montenegro MR; de Almeida MR; Hossne WS
    Arq Gastroenterol; 1983; 20(3):92-102. PubMed ID: 6677256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term cross-circulation on galactosamine induced hepatic failure rats].
    Okabe K; Koyama K; Ouchi K; Asanuma Y; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):445-51. PubMed ID: 6749112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the permeability of the blood-brain barrier in experimental diabetes.
    Lorenzi M; Healy DP; Hawkins R; Printz JM; Printz MP
    Diabetologia; 1986 Jan; 29(1):58-62. PubMed ID: 2937677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of fibronectin in galactosamine-induced liver failure in rats.
    Moriyama T; Aoyama H; Ohnishi S; Imawari M
    Hepatology; 1986; 6(6):1334-9. PubMed ID: 3793010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.